Soleno Therapeutics, Inc. (SLNO) Misses Q3 EPS by 122c

Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q3 EPS of ($1.83), $1.22 worse than the analyst estimate of ($0.61).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.

You May Also Be Interested In

• Key things to know ahead of SK Hynix’s blockbuster US listing
• Meta launches first paid AI developer model with new API - Bloomberg
• Micron Technology (MU) call put ratio 1.3 calls to 1 put with a focus July weekly options as share price up 6.9%